These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28765478)

  • 1. Valacyclovir-associated neurotoxicity treated with intensification of peritoneal dialysis.
    Prasad B; McIsaac M; Toppings J
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28765478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
    Chaudhari D; Ginn D
    Am J Ther; 2014; 21(6):e215-7. PubMed ID: 23528373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Iwasawa H; Nanri K; Yamazaki T
    Clin Nephrol; 2002 Aug; 58(2):168-70. PubMed ID: 12227692
    [No Abstract]   [Full Text] [Related]  

  • 4. Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.
    Hoskote SS; Annapureddy N; Ramesh AK; Rose K; Jones JP
    Am J Ther; 2016; 23(1):e304-6. PubMed ID: 24368610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of acyclovir neurotoxicity presenting with atypical cerebrospinal fluid findings.
    Thind GS; Roach R
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensification of peritoneal dialysis improves valacyclovir neurotoxicity.
    Pipili C; Pantelias K; Deda E; Tsiamalos P; Kostis E; Grapsa E
    Ren Fail; 2013; 35(2):289-90. PubMed ID: 23176110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valacyclovir neurotoxicity can be effectively managed by hemodialysis.
    Kambhampati G; Pakkivenkata U; Kazory A
    Eur J Neurol; 2011 Mar; 18(3):e33. PubMed ID: 21087359
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neurotoxicity of valacyclovir in a peritoneal dialysis patient].
    Takayanagi A; Maehana T; Kyoda Y; Yanase M
    Hinyokika Kiyo; 2010 Nov; 56(11):617-9. PubMed ID: 21187705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir neurotoxicity: clinical experience and review of the literature.
    Asahi T; Tsutsui M; Wakasugi M; Tange D; Takahashi C; Tokui K; Okazawa S; Okudera H
    Eur J Neurol; 2009 Apr; 16(4):457-60. PubMed ID: 19187258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity of acyclovir and valacyclovir in a hemodialyzed patient.
    Strumia S; De Mitri P; Bionda E
    Eur J Neurol; 2004 Jan; 11(1):68-9. PubMed ID: 14692893
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epilepticus status and valaciclovir in chronic renal failure].
    Rodríguez Uranga JJ; Franco Macías E; Delgado López F; Villalobos Chávez F
    Med Clin (Barc); 2004 Sep; 123(10):399. PubMed ID: 15482711
    [No Abstract]   [Full Text] [Related]  

  • 12. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
    Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
    J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Periodic synchronous discharge occurred in an elderly with acute valacyclovir-associated encephalopathy].
    Nakatani M; Tsukino M; Takahashi R; Ikeda A
    Rinsho Shinkeigaku; 2016 Jul; 56(7):504-7. PubMed ID: 27356736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.
    Tyring SK; Lee P; Hill GT; Silverfield JC; Moore AY; Matkovits T; Sullivan-Bolyai J
    J Med Virol; 2017 Jul; 89(7):1255-1264. PubMed ID: 27943311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
    Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
    J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acyclovir-induced neurotoxicity and acute kidney injury in an elderly diabetic patient treated with valacyclovir: report of a case].
    Sagawa N; Tsurutani Y; Nomura K; Okuyama T; Kondo M; Sata A; Miyao M; Mizuno Y
    Nihon Ronen Igakkai Zasshi; 2014; 51(6):581-5. PubMed ID: 25749332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML; Murray A; de Miranda P
    Adv Exp Med Biol; 1996; 394():33-9. PubMed ID: 8815698
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity caused by valacyclovir in a patient on hemodialysis.
    Linssen-Schuurmans CD; van Kan EJ; Feith GW; Uges DR
    Ther Drug Monit; 1998 Aug; 20(4):385-6. PubMed ID: 9712461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valacyclovir-induced Neurotoxicity in a Patient with a Preserved Renal Function.
    Yoshimura T; Kawasaki T; Shirota A; Saeki M; Okada Y; Okada H
    Intern Med; 2018 Nov; 57(21):3213-3216. PubMed ID: 29877263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.